Discerna Ltd.
http://www.babraham.ac.uk
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Discerna Ltd.
Antikor Takes Aim At Solid Tumors With Antibody-Fragment Conjugates
Emerging Company Profile: The UK's Antikor Biopharma is advancing antibody fragment-drug conjugates (FDCs) closer to the clinic with plans for its first human study in 2019 or 2020.
Isogenica Ltd.
Covalent Display Technology (CDT) is a fully in vitro display library platform, around which Isogenica Ltd. was founded in December 2000 . Its founders believe that CDT's properties--which allow the rapid construction of very large, easily automated libraries of diverse collections of biological compounds--offer clear advantages over existing phage display methods.
Company Information
- Industry
- Pharmaceuticals
-
Biotechnology
-
Large Molecule
- Antibodies
-
Large Molecule
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice